ArticleThe oncologist2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers.
Kim M Hirshfield et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this paperpooled itcites it